Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus

Frontiers in Immunology

Immunology

Nicole E. Skinner¹  Anuj Gupta²  Sarah Wheelan²  Kornel Schuebel²  Jennifer Meyers²  Srinivasan Yegnasubramanian²  James E. Crowe³  Kaitlyn E. Clark⁴  Clinton O. Ogega⁴  Nicole Frumento⁴  Harry Paul⁴  Justin R. Bailey⁴  Andrea L. Cox⁵  Stuart C. Ray⁵ 

[1] Center for Vaccines and Immunity, The Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, OH, United States;Department of Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States;Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States;Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, United States;Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, United States;Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, United States;Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States;Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States;Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, United States;

关键词: hepatitis C virus;    B cell;    neutralizing antibody;    B cell receptor;    vaccine;   

DOI  :  10.3389/fimmu.2023.1201033

 received in 2023-04-05, accepted in 2023-04-18,  发布年份 2023

来源: Frontiers

【 授权许可】

Unknown   
Copyright © 2023 Skinner, Ogega, Frumento, Clark, Paul, Yegnasubramanian, Schuebel, Meyers, Gupta, Wheelan, Cox, Crowe, Ray and Bailey